These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12679744)

  • 21. The Impact of Psychiatric Practice Guidelines on Medication Costs and Youth Aggression in a Juvenile Justice Residential Treatment Program.
    Lee TG; Walker SC; Bishop AS
    Psychiatr Serv; 2016 Feb; 67(2):214-20. PubMed ID: 26423102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of maladaptive aggression in youth: CERT guidelines I. Engagement, assessment, and management.
    Knapp P; Chait A; Pappadopulos E; Crystal S; Jensen PS;
    Pediatrics; 2012 Jun; 129(6):e1562-76. PubMed ID: 22641762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacologic treatment of aggression in children and adolescents.
    Ruths S; Steiner H
    Pediatr Ann; 2004 May; 33(5):318-27. PubMed ID: 15162638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated treatment of aggression in the context of ADHD in children refractory to stimulant monotherapy: a window into the future of child psychopharmacology.
    Steiner H; Karnik NS
    Am J Psychiatry; 2009 Dec; 166(12):1315-7. PubMed ID: 19952080
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychopharmacologic treatment in juvenile offenders.
    Soller MV; Karnik NS; Steiner H
    Child Adolesc Psychiatr Clin N Am; 2006 Apr; 15(2):477-99, x. PubMed ID: 16527667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: A systematic review.
    Goedhard LE; Stolker JJ; Heerdink ER; Nijman HL; Olivier B; Egberts TC
    J Clin Psychiatry; 2006 Jul; 67(7):1013-24. PubMed ID: 16889443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy of impulsive aggression: a quality comparison of controlled studies.
    Felthous AR; Lake SL; Rundle BK; Stanford MS
    Int J Law Psychiatry; 2013; 36(3-4):258-63. PubMed ID: 23642319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychopharmacology of conduct disorder: current progress and future directions.
    Tcheremissine OV; Cherek DR; Lane SD
    Expert Opin Pharmacother; 2004 May; 5(5):1109-16. PubMed ID: 15155112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should relational aggression be included in DSM-V?
    Keenan K; Coyne C; Lahey BB
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):86-93. PubMed ID: 18174829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability.
    Parikh MS; Kolevzon A; Hollander E
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):157-78. PubMed ID: 18439113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline predictors of response to divalproex in conduct disorder.
    Saxena K; Silverman MA; Chang K; Khanzode L; Steiner H
    J Clin Psychiatry; 2005 Dec; 66(12):1541-8. PubMed ID: 16401155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical models of conduct disorder - principles and pharmacologic perspectives.
    Haller J
    Neurosci Biobehav Rev; 2018 Aug; 91():112-120. PubMed ID: 27238913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptomatic response to divalproex in subtypes of conduct disorder.
    Padhy R; Saxena K; Remsing L; Huemer J; Plattner B; Steiner H
    Child Psychiatry Hum Dev; 2011 Oct; 42(5):584-93. PubMed ID: 21706221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing anger and aggression in patients with posttraumatic stress disorder.
    Yehuda R
    J Clin Psychiatry; 1999; 60 Suppl 15():33-7. PubMed ID: 10418813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.
    Frye MA; Eudicone J; Pikalov A; McQuade RD; Marcus RN; Carlson BX
    J Clin Psychopharmacol; 2008 Apr; 28(2):243-5. PubMed ID: 18344741
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the pharmacotherapy of aggression in children and adolescents.
    Stewart JT; Myers WC; Burket RC; Lyles WB
    J Am Acad Child Adolesc Psychiatry; 1990 Mar; 29(2):269-77. PubMed ID: 2182611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mood stabilizers and anticonvulsants.
    Kowatch RA; Bucci JP
    Pediatr Clin North Am; 1998 Oct; 45(5):1173-86, ix-x. PubMed ID: 9884681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Child behaviour checklist emotional dysregulation profiles in youth with disruptive behaviour disorders: clinical correlates and treatment implications.
    Masi G; Muratori P; Manfredi A; Pisano S; Milone A
    Psychiatry Res; 2015 Jan; 225(1-2):191-196. PubMed ID: 25480545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting.
    Correll CU; Yu X; Xiang Y; Kane JM; Masand P
    Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.